AI in Biotech Commercial Operations

Practical applications of AI across biotech commercial teams including forecasting, territory optimization, KOL targeting, and launch planning.

AI key account management in biotech: from relationship tracking to revenue intelligence

AI key account management in biotech: from relationship tracking to revenue intelligence

AI in Biotech Commercial Operations /

AI key account management in biotech: from relationship tracking to revenue intelligence Most biotech key account management runs on structured relationships and manual updates. Account plans are written once a quarter. CRM entries are filed after the call. Insights arrive weeks after the conversation. AI changes this. Not by replacing the account manager, but by […]

AI key account management in biotech: from relationship tracking to revenue intelligence Read More »

Dark cinematic banner with Eli Lilly logo and Foundayo oral GLP-1 FDA approval headline on molecular data background

Lilly’s Foundayo FDA Approval Resets the GLP-1 Commercial Playbook

AI in Biotech Commercial Operations /

The FDA approved Foundayo (orforglipron) by Eli Lilly on April 1 2026 as a once-daily oral GLP-1 for obesity. With no food restrictions, small-molecule manufacturing, $25 monthly pricing with insurance, and a DTC launch through LillyDirect, Foundayo resets access and distribution assumptions across the entire GLP-1 market. Analysts forecast $14.79 billion in sales by 2030.

Lilly’s Foundayo FDA Approval Resets the GLP-1 Commercial Playbook Read More »

Abstract visualization of pharmaceutical pricing data flowing through a distribution network

How AI Closes the $356 Billion Distributor Margin Gap in Biotech

AI in Biotech Commercial Operations /

The pharma gross-to-net bubble reached $356 billion in 2024, driven by rebates, chargebacks, and distributor fees. AI tools now enable real-time GTN monitoring, smarter distributor demand forecasting, and dynamic channel pricing. Companies adopting these approaches report 9% margin expansion and 17% better tender win rates.

How AI Closes the $356 Billion Distributor Margin Gap in Biotech Read More »